Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Kyung Hong and Hong Kim.
Kyung Hong
Connection Strength
0.625
Hong Kim
  1. GSK-LSD1, an LSD1 inhibitor, quashes SARS-CoV-2-triggered cytokine release syndrome in-vitro. Signal Transduct Target Ther. 2020 11 17; 5(1):267.
    View in: PubMed
    Score: 0.228
  2. Early Hydroxychloroquine Administration for Rapid Severe Acute Respiratory Syndrome Coronavirus 2 Eradication. Infect Chemother. 2020 Sep; 52(3):396-402.
    View in: PubMed
    Score: 0.223
  3. PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives ameliorate SARS-CoV-2-mediated hyper-inflammatory responses. Biomaterials. 2021 06; 273:120827.
    View in: PubMed
    Score: 0.059
  4. Lung-selective 25-hydroxycholesterol nanotherapeutics as a suppressor of COVID-19-associated cytokine storm. Nano Today. 2021 Jun; 38:101149.
    View in: PubMed
    Score: 0.059
  5. COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm. Signal Transduct Target Ther. 2020 09 03; 5(1):186.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.